Investment 25 March 2026 - 27 March 2026

3i Group shares rose 2.9% Friday after plunging 17.6% Thursday on weaker 2026 guidance from Action, which makes up 76% of 3i’s private equity value. Action expects like-for-like sales growth of 4–5% next year and plans its first U.S. stores by 2028. Barclays cut its price target for 3i to 4,455 pence. 3i reports full-year results in May.

LIVEMarkets rolling coverageStarted: March 27, 2026, 12:00 AM EDTUpdated: March 27, 2026, 11:59 PM EDT 6 Key Numbers to Assess Pro Medicus Ltd (ASX:PME) Shares in 2024 March 27, 2026, 11:51 PM EDT. The Pro Medicus Ltd (ASX:PME) share price has fallen 47.13% year-to-date. Key metrics shed light on its outlook. The company, specializing in radiology IT software, posted $162 million in revenue, growing at 33.4% CAGR over three years. Its gross margin is an impressive 99.8%, reflecting core operational strength. Profit climbed from $31 million to $83 million over three years, a 39.0% CAGR. Financially, PME holds net debt

Informa Plc shares fell 0.4% to 764.2p as the FTSE 100 dropped 1.3% and oil prices surged above $105 a barrel. The company delayed Middle East events amid regional tensions but reported record 2025 revenue of £4.04 billion and raised its 2026 buyback target to £250 million. Management reaffirmed 2026 guidance despite shifting event dates. About 40% of 2026 IMEA revenue is already secured.

Barclays shares fell 2.8% in early London trading after Reuters reported the bank is retreating from some smaller collateral-backed loans following losses tied to Market Financial Solutions and Tricolor Holdings. Barclays is owed £495 million from MFS. The FTSE 100 dropped 1.1% amid broader market weakness. Investors await the FCA’s motor-finance compensation plan, which could impact several major lenders.

GSK shares traded at 2,057p midday Thursday, up 0.15% after gains earlier in the week, even as London’s FTSE 100 dropped over 1%. The company bought 345,000 of its own shares on March 25, bringing total buybacks since Feb. 17 to 14.86 million. Recent FDA approval of Lynavoy and acquisitions of 35Pharma and RAPT Therapeutics drew attention, but broker ratings stayed cautious.

LIVEMarkets rolling coverageStarted: March 26, 2026, 12:00 AM EDTUpdated: March 26, 2026, 11:58 PM EDT Top 10 ASX Gainers on Friday Include Whitehaven Coal and New Hope March 26, 2026, 11:58 PM EDT. On Friday, Whitehaven Coal (WHC) led gains among ASX-listed firms, rising 3% to AU$9.13. New Hope (NHC) also climbed 3% to AU$5.63. Other notable movers were Telix Pharmaceuticals (TLX) and Yancoal Australia (YAL), each up 2%, closing at AU$13.29 and AU$8.28 respectively. Smaller advances of 1-3% were seen in 4D Medical (4DX), a2 Milk (A2M), Life360 (360), News Corp (NWS), Ampol (ALD), and Harvey Norman Holdings (HVN).

London Stock Exchange Group shares rose to 8,548 pence on Wednesday, up from 8,474 pence. FTSE Russell, owned by LSEG, extended its data partnership with CanDeal DNA for 10 years. The stock remains below its 52-week high after earlier pressure from AI concerns and Elliott Management’s campaign for changes. The FTSE 100 index gained 1.1% amid reports of a possible U.S.-brokered ceasefire proposal to Iran.

RELX shares fell about 1% to 2,407 pence in London on Wednesday, underperforming the FTSE 100 despite a new £350 million buyback. The stock remains below last week’s 2,565 pence share sale price as investors weigh risks from generative AI competition and ongoing large share sales. RELX reported 2025 revenue of £9.59 billion and 7% underlying growth. J.P. Morgan is executing the current buyback through April 22.

Experian shares fell 1.6% to 2,524.5 pence in London Wednesday despite announcing the repurchase and cancellation of about 1.18 million shares over two days. Investors remain focused on U.S. credit-score pricing pressure ahead of full-year results in May. Peer companies Fair Isaac, Equifax, and TransUnion also dropped after U.S. officials called for more affordable credit-score pricing.

National Grid shares rose 1.8% to 1,254 pence Wednesday after Bernstein Research raised its price target to 1,450 pence and reiterated an outperform rating. Goldman Sachs downgraded the stock to neutral earlier in the week, citing valuation after a recent rally. National Grid recently set a five-year capital spending target of at least £70 billion and expects underlying EPS growth of 8%-10% from FY26.

Rolls-Royce shares rose 2.1% to 1,190.5 pence in London after the company bought back 1.01 million shares for cancellation, bringing total repurchases to 21.46 million. Rolls-Royce also announced a £19.3 million investment to double output at its Rotherham turbine-blade plant by 2030. The FTSE 100 gained 1.1%.